Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Complete Response Letter (CRL) - Ink World Magazine

Complete Response Letter (CRL)

Issued by the U.S. FDA when communicating a decision to a drug company that an NDA or ANDA to market a new or generic drug will not be approved in its present form. Before August 2008, the FDA used Approvable and Not Approvable letters in these cases, but moved to CRLs to “provide a more consistent and neutral mechanism to convey that our initial review of an application is complete and we cannot approve the application in its present form,” according to an FDA statement. For BLAs, the FDA has used CRLs since 1998.

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters